206 related articles for article (PubMed ID: 32366893)
1. Lithium response in bipolar disorder correlates with improved cell viability of patient derived cell lines.
Paul P; Iyer S; Nadella RK; Nayak R; Chellappa AS; Ambardar S; Sud R; Sukumaran SK; Purushottam M; Jain S; ; Viswanath B
Sci Rep; 2020 May; 10(1):7428. PubMed ID: 32366893
[TBL] [Abstract][Full Text] [Related]
2. RNA sequencing of bipolar disorder lymphoblastoid cell lines implicates the neurotrophic factor HRP-3 in lithium's clinical efficacy.
Milanesi E; Voinsky I; Hadar A; Srouji A; Maj C; Shekhtman T; Gershovits M; Gilad S; Chillotti C; Squassina A; Potash JB; Schulze TG; Goes FS; Zandi P; Kelsoe JR; Gurwitz D
World J Biol Psychiatry; 2019 Jul; 20(6):449-461. PubMed ID: 28854847
[No Abstract] [Full Text] [Related]
3. Analysis on in vitro effect of lithium on telomere length in lymphoblastoid cell lines from bipolar disorder patients with different clinical response to long-term lithium treatment.
Squassina A; Meloni A; Congiu D; Bosganas P; Patrinos GP; Lin R; Turecki G; Severino G; Ardau R; Chillotti C; Pisanu C
Hum Genomics; 2022 Oct; 16(1):45. PubMed ID: 36253798
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor 1 (IGF-1) expression is up-regulated in lymphoblastoid cell lines of lithium responsive bipolar disorder patients.
Squassina A; Costa M; Congiu D; Manchia M; Angius A; Deiana V; Ardau R; Chillotti C; Severino G; Calza S; Del Zompo M
Pharmacol Res; 2013 Jul; 73():1-7. PubMed ID: 23619527
[TBL] [Abstract][Full Text] [Related]
5. Lithium response in bipolar disorder: No difference in GADL1 gene expression between cell lines from excellent-responders and non-responders.
Moreira J; Courtin C; Geoffroy PA; Curis E; Bellivier F; Marie-Claire C
Psychiatry Res; 2017 May; 251():217-220. PubMed ID: 28214779
[TBL] [Abstract][Full Text] [Related]
6. Distinct lithium-induced gene expression effects in lymphoblastoid cell lines from patients with bipolar disorder.
Fries GR; Colpo GD; Monroy-Jaramillo N; Zhao J; Zhao Z; Arnold JG; Bowden CL; Walss-Bass C
Eur Neuropsychopharmacol; 2017 Nov; 27(11):1110-1119. PubMed ID: 28939162
[TBL] [Abstract][Full Text] [Related]
7. Neural progenitor cells derived from lithium responsive and non-responsive bipolar disorder patients exhibit distinct sensitivity to cell death following methamphetamine.
Mishra HK; Mandyam AD; Trenet W; Wei H; Nievergelt CM; Maihofer AX; Shilling PD; Alda M; Gershon E; McInnis MG; ; Kelsoe JR; McCarthy MJ
Neuropharmacology; 2023 Mar; 226():109410. PubMed ID: 36608815
[TBL] [Abstract][Full Text] [Related]
8. Evidence towards RNA Binding Motif (RNP1, RRM) Protein 3 (RBM3) as a Potential Biomarker of Lithium Response in Bipolar Disorder Patients.
Papadima EM; Niola P; Melis C; Pisanu C; Congiu D; Cruceanu C; Lopez JP; Turecki G; Ardau R; Severino G; Chillotti C; Del Zompo M; Squassina A
J Mol Neurosci; 2017 Aug; 62(3-4):304-308. PubMed ID: 28616776
[TBL] [Abstract][Full Text] [Related]
9. Lithium-associated transcriptional regulation of CRMP1 in patient-derived olfactory neurons and symptom changes in bipolar disorder.
McLean CK; Narayan S; Lin SY; Rai N; Chung Y; Hipolito MS; Cascella NG; Nurnberger JI; Ishizuka K; Sawa AS; Nwulia EA
Transl Psychiatry; 2018 Apr; 8(1):81. PubMed ID: 29666369
[TBL] [Abstract][Full Text] [Related]
10. Lithium-induced Clock Gene Expression in Lymphoblastoid Cells of Bipolar Affective Patients.
Kittel-Schneider S; Schreck S; Ziegler C; Weißflog L; Hilscher M; Schwarz R; Schnetzler L; Neuner M; Reif A
Pharmacopsychiatry; 2015 Jul; 48(4-5):145-9. PubMed ID: 26011568
[TBL] [Abstract][Full Text] [Related]
11. Lithium-responsive genes and gene networks in bipolar disorder patient-derived lymphoblastoid cell lines.
Breen MS; White CH; Shekhtman T; Lin K; Looney D; Woelk CH; Kelsoe JR
Pharmacogenomics J; 2016 Oct; 16(5):446-53. PubMed ID: 27401222
[TBL] [Abstract][Full Text] [Related]
12. Leukocyte telomere length positively correlates with duration of lithium treatment in bipolar disorder patients.
Squassina A; Pisanu C; Congiu D; Caria P; Frau D; Niola P; Melis C; Baggiani G; Lopez JP; Cruceanu C; Turecki G; Severino G; Bocchetta A; Vanni R; Chillotti C; Del Zompo M
Eur Neuropsychopharmacol; 2016 Jul; 26(7):1241-7. PubMed ID: 27084304
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin genes expressed in lymphoblastoid cell lines discern and predict lithium response in bipolar disorder patients.
Mizrahi L; Choudhary A; Ofer P; Goldberg G; Milanesi E; Kelsoe JR; Gurwitz D; Alda M; Gage FH; Stern S
Mol Psychiatry; 2023 Oct; 28(10):4280-4293. PubMed ID: 37488168
[TBL] [Abstract][Full Text] [Related]
14. Lithium effects on serine-threonine kinases activity: High throughput kinomic profiling of lymphoblastoid cell lines from excellent-responders and non-responders bipolar patients.
Moreira J; Noé G; Rangarajan S; Courtin C; Etain B; Geoffroy PA; Laplanche JL; Vidal M; Bellivier F; Marie-Claire C
World J Biol Psychiatry; 2020 Apr; 21(4):317-324. PubMed ID: 29893160
[No Abstract] [Full Text] [Related]
15. Insulin-like Growth Factor 1 Differentially Affects Lithium Sensitivity of Lymphoblastoid Cell Lines from Lithium Responder and Non-responder Bipolar Disorder Patients.
Milanesi E; Hadar A; Maffioletti E; Werner H; Shomron N; Gennarelli M; Schulze TG; Costa M; Del Zompo M; Squassina A; Gurwitz D
J Mol Neurosci; 2015 Jul; 56(3):681-7. PubMed ID: 25740013
[TBL] [Abstract][Full Text] [Related]
16. Novel integrative genomic tool for interrogating lithium response in bipolar disorder.
Hunsberger JG; Chibane FL; Elkahloun AG; Henderson R; Singh R; Lawson J; Cruceanu C; Nagarajan V; Turecki G; Squassina A; Medeiros CD; Del Zompo M; Rouleau GA; Alda M; Chuang DM
Transl Psychiatry; 2015 Feb; 5(2):e504. PubMed ID: 25646593
[TBL] [Abstract][Full Text] [Related]
17. Lithium-induced gene expression alterations in two peripheral cell models of bipolar disorder.
Kittel-Schneider S; Hilscher M; Scholz CJ; Weber H; Grünewald L; Schwarz R; Chiocchetti AG; Reif A
World J Biol Psychiatry; 2019 Jul; 20(6):462-475. PubMed ID: 29067888
[No Abstract] [Full Text] [Related]
18. Clinical factors associated with lithium treatment response in bipolar disorder patients from India.
Kapur V; Nadella RK; Sathur Raghuraman B; Saraf G; Mishra S; Srinivasmurthy N; Jain S; Del Zompo M; Viswanath B
Asian J Psychiatr; 2019 Jan; 39():165-168. PubMed ID: 29636228
[TBL] [Abstract][Full Text] [Related]
19. Exploring Genetic Variability at PI, GSK3, HPA, and Glutamatergic Pathways in Lithium Response: Association With IMPA2, INPP1, and GSK3B Genes.
Mitjans M; Arias B; Jiménez E; Goikolea JM; Sáiz PA; García-Portilla MP; Burón P; Bobes J; Vieta E; Benabarre A
J Clin Psychopharmacol; 2015 Oct; 35(5):600-4. PubMed ID: 26267417
[TBL] [Abstract][Full Text] [Related]
20. A gene co-expression module implicating the mitochondrial electron transport chain is associated with long-term response to lithium treatment in bipolar affective disorder.
Stacey D; Schubert KO; Clark SR; Amare AT; Milanesi E; Maj C; Leckband SG; Shekhtman T; Kelsoe JR; Gurwitz D; Baune BT
Transl Psychiatry; 2018 Sep; 8(1):183. PubMed ID: 30185780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
